VULNAMIN® induces re-epithelialisation of the wound, which is associated with a marked reduction in inflammatory infiltrate and colonisation of the lesion by newly formed vessels VULNAMIN® has been clinically shown to induce a rapid and progressive reduction in wound size, and to of wounds.
Dry cleansed lesions or Necrotic lesions
Gel formulation with hydrolysis effect of necrotic tissue, with a cleansing effect allowing the mixture of Hyaluronic Acid and Amino Acids to exert the induction effect of the granulation tissue.
Clean Wounds with low to medium exudate or Excoriations
Cream formulation that maintains moisture and promotes tissue regeneration on ulcers of various etiology and pressure injuries.
Wounds with medium to high exudate
Powder formulation for topical use indicated for the treatment of lesions with the presence of abundant exudate.
Fluid spray gel formulation adjuvant in the prevention and treatment of pressure injuries of Grade 1 pressure injuries (stable erythema). The product is also indicated for the treatment of chronic skin ulcers of various origins, even with the presence of fibrin cloth.
Management of nutritional deficiencies
With Glutamine, Proline and Essential Aminoacids.
Vulnamin WH is indicated for the dietary treatment of protein malnutrition in acute and chronic medical conditions associated with significant tissue damage:
- surgical wounds
- pressure sores
- diabetic foot ulcers
- impaired wound healing (delay of complete tissue repair)
Find out more about other therapeutical areas